Islet cell autoimmunity in women with gestational diabetes and risk of progression to insulin-dependent diabetes mellitus

Diabetes/Metabolism Reviews

Volumn 12, Issue 4, 1996, Pages 275-285

  Mauricio, Dídac ^a,b   Balsells, Montse ^a   Morales, Josefa ^a   Corcoy, Rosa ^a   Puig Domingo, Manel ^a   De Leiva, Alberto ^a,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Department of Pediatrics   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADULT; AUTOIMMUNITY; ETHNOLOGY; FEMALE; GLUCOSE TOLERANCE TEST; HEREDITY; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR;

EID: 0030483526     PISSN: 07424221     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0895(199612)12:4<275::AID-DMR170>3.0.CO;2-W     Document Type: Review

References (66)

1. Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI, Cuartero BG, Karlsen AE, Bjerre U and Lorenzen T: On the pathogenesis of IDDM. Diabetologia 37 (Suppl. 2): S82-S89, 1994.
2. Eisenbarth GS: Type I diabetes mellitus: a chronic autoimmune disease, N Engl J Med 314: 1360-1368, 1986.
3. Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, and Cudworth AG: Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet ii: 1363-1365, 1980.
4. Palmer JP: Predicting IDDM: use of humoral immune markers. Diabetes Rev 1: 104-115, 1992.
5. Srikanta S, Ganda OP, Jackson RA, Brink SJ, Fleischnick E, Yunis E, Alper C, Soeldner JS, and Eisenbarth GS: Pre-type 1 (insulin-dependent) diabetes: common endocrinological course despite immunological and immunogenetic heterogeneity. Diabetologia 27: 146-149, 1984.
6. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057, 1979.
7. Freinkel N, Metzger BE, Phelps RL, Simpson JL, Martin AO, Radvany R, Ober C, Dooley SL, Depp RO, and Belton A: Gestational diabetes mellitus: a syndrome with phenotypic and genotypic heterogeneity. Horm Metab Res 18: 427-430, 1987.
8. O'Sullivan JB. Diabetes mellitus after GDM. Diabetes 29 (Suppl. 2): 131-135, 1991.
9. Mauricio D, Morales J, Corcoy R, Puig-Domingo M, Pou JM, and de Leiva A: Immunology of gestational diabetes: heterogeneity of islet cell antibodies. Diabetes Rev 4: 36-48, 1996.
10. Damm P, Kühl C, Buschard K, Jakobsen BK, Svejgaard A, Sodoyez-Goffaux F, Shattock M, Bottazzo GF, and Mølsted-Petersen L: Prevalence and predictive value of islet cell antibodies and insulin antibodies in women with gestational diabetes. Diabetic Med 11: 558-563, 1994.
11. Damm P, Petersen J, Dyrberg T, Buschard K, Kühl C, and Mølsted-Pedersen L: Prevalence and predictive value of GAD65 autoantibodies in women with gestational diabetes (Abstract). Diabetologia 38 (Suppl. 1): A70, 1995.
12. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, Tuomilehto-Wolf E, Kohtamäki K, Stengård J, and Rowley MJ: Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343: 1383-1385, 1994.
13. Harrison LC: Islet cell antibodies: light at the end of the tube? Diabetes Care 10: 1220-1222, 1994.
14. Steel JM, Irvine WJ, and Clarke BF: The significance of pancreatic islet cell antibody and abnormal glucose tolerance during pregnancy. J Clin Lab Immunol 4: 83-85, 1980.
15. Ginsberg-Fellner F, Mark EM, Nechemias C, Hausknecht RU, Rubinstein P, Dobersen MJ, and Notkins AL: Islet cell antibodies in gestational diabetics (Letter). Lancet ii: 362-363, 1980.
16. Rubinstein P, Walker M, Krassner J, Carrier C, Carpenter C, Dobersen MJ, Notkins AL, Mark EM, Nechemias C, Hausknecht RU, and Ginsberg-Fellner F: HLA antigens and islet cell antibodies in gestational diabetes. Hum Immunol 3: 271-275, 1981.
17. Fallucca F, Di Mario U, Gargiulo P, Iavicoli M, Galfo C, Contreas G, Pachí A, and Andreani D: Humoral immunity in diabetic pregnancy: interrelationships with maternal/neonatal complications and maternal metabolic control. Diabete Metab 11: 387-395, 1985.
18. Freinkel N, Metzger BE, Phelps RL, Dooley SL, Ogata ES, Radvany RM, and Belton A: Gestational diabetes mellitus: heterogeneity of maternal age, weight, insulin secretion, HLA antigens, and islet cell antibodies and the impact of maternal metabolism on pancreatic B-cell and somatic development in the offspring. Diabetes 34 (Suppl. 2): 1-7, 1985.
19. Catalano PM, Tyzbir ED, and Sims EAH: Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care 13: 478-482, 1990.
20. Bell DSH, Barger BO, Go RCP, Goldenberg RL, Perkins LL, Vanichanan CJ, Roseman J, and Acton RT: Risk factors for gestational diabetes in black population. Diabetes Care 13 (Suppl. 4): 1196-1201, 1990.
21. Mauricio D, Corcoy R, Codina M, Balsells M, Puig-Domingo M, Pou JM, and de Leiva A: Islet cell antibodies identify a subset of gestational diabetic women with higher risk of developing diabetes mellitus shortly after pregnancy. Diabetes Nutr Metab 5: 237-241, 1992.
22. Ziegler AG, Hillebrand B, Rabl W, Mayrhofer M, Hummel M, Mollenhauer U, Vordemann J, Lenz A, and Standl E: On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth. Diabetologia 36: 402-108, 1993.
23. Yagigashi S, Suzuki H, Dobersen MJ, Onodera T, Notkins AL, and Ginsberg-Fellner F: Autoantibodies to islet cells: comparison of methods (Letter). Lancet ii: 1218, 1982.
24. McEvoy RC, Franklin B, and Ginsberg-Fellner F: Gestational diabetes mellitus: evidence for autoimmunity against the pancreatic beta cells. Diabetologia 34: 507-510, 1991.
25. Stowers JM, Sutherland HW, and Kerridge DF: Long-range implications for the mother: the Aberdeen experience. Diabetes 34 (Suppl. 2): 106-110, 1985.
26. Palmer JP, Asplin CH, and Clemons P: Insulin antibodies in insulin dependent diabetics before insulin treatment. Science 222: 1337-1339, 1982.
27. Karjalainen J, Salmena P, Ilonen J, Surcel HM, and Knip M: A comparison of childhood and adult type I diabetes mellitus. N Engl J Med 320: 881-886, 1989.
28. Srikanta S, Richter AT, MacCulloch DK, Soeldner JS, Eisenbarth GS, and Palmer JP: Autoimmunity to insulin, beta-cell dysfunction and development of insulin-dependent diabetes mellitus. Diabetes 36: 139-142, 1986.
29. Wilkin TJ: Insulin antibodies as markers for type I diabetes. Endocr Rev 11: 92-104, 1990.
30. Vardi P, Dib SA, Tuttleman M, Conelly SE, Grinbergs M, Rabizadeh A, Riley WJ, Maclaren NK, Eisenbarth GS, and Soeldner JS: Competitive insulin antibody assay: prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes 36: 1286-1291, 1987.
31. Maclaren NK: How, when, and why to predict IDDM. Diabetes 37: 1591-1594, 1988.
32. Palmer JP, Wilkin TJ, Kurtz AB, and Bonifacio E: The third International Workshop on the standardisation of insulin autoantibody measurement. Diabetologia 33: 60-61, 1990.
33. Greenbaum CJ, Wilkin TJ, and Palmer JP: Fifth International Exchange Workshop for Insulin Autoantibody (IAA) standardization. Diabetologia 35: 798-800, 1992.
34. Levy-Marchal C, Bridel MP, Sodoyez-Goffaux F, Koch M, Tichet J, Czernichow P, and Sodoyez JC: Superiority of radiobinding assay over ELISA for detection of LAAs in newly diagnosed type I diabetic children. Diabetes Care 14: 61-63, 1991.
35. Puig-Domingo M, Mauricio D, Morales J, Pérez A, Pimental A, Rodríguez-Rigual M, Vazquez JA, Igea JM, Quintana B, Alonso M, Barrio R, Calle H, Manzano P, Antona J, Flández B, Moreiro J, Binimelis J, Codina M, Julia R, and de Leiva A: Proyecto de la Sociedad Española de Diabetes sobre prediabetes tipo 1. Av Diabetol 5 (Suppl. 2): 57-65, 1992.
36. De Aizpurua HJ and Harrison LC: Glutamic acid decarboxylase in insulin-dependent diabetes mellitus. Diabetes Metab Rev 8: 133-147, 1992.
37. Beischer NA, Wein P, Sheedy MT, Mackay IR, Rowley MJ, and Zimmet P: Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes. Am J Obstet Gynecol 173: 1563-1569, 1995.
38. Fallucca F, Tiberti C, Torresi P, Napoli A, Cardellini G, Sciullo E, Dotta F, Falorni A, Lermark Å, and Di Mario U: Presence of anti-GAD65 autoantibodies in women with gestational diabetes mellitus (Abstract). Autoimmunity 21: 74, 1995.
39. Payton MA, Hawkes CJ, and Christie MR: Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phophatase-like molecule IA-2 (ICA512). J Clin Invest 96: 1506-1511, 1995.
40. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, and Gale EAM: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43: 1304-1310, 1994.
41. Bonifacio E, Genovese S, Braghi S, Bazzigalupi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale EAM, and Bosi E: Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38: 816-822, 1995.
42. Mauricio D, Corcoy R, Balsells M, Giménez G, Adelantado JM, and de Leiva A: Higher frequency of short term post-partum diabetes and glucose intolerance among ICA positive gestational diabetic women (Abstract). Diabetes 42 (Suppl. 1): 72A, 1993.
43. Mauricio D, Corcoy R, Codina M, Morales J, Balsells M, and de Leiva A: Islet cell antibodies and beta cell function in gestational diabetic women: comparison to first-degree relatives of type 1 (insulin-dependent) diabetic subjects. Diabetic Med 12: 1009-1014, 1995.
44. Gianani T, Pugliese A, Bonner-Weir S, Shiffrin AJ, Soeldner JS, Erlich H, Awdeh Z, Alper CA, Jackson RA, and Eisenbarth GS: Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives with type 1 diabetes. Diabetes 41: 347-353, 1992.
45. Genovese S, Bonifacio E, McNally JM, Dean BM, Wagner R, Bosi E, Gale EAM, and Bottazzo GF: Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 385-388, 1992.
46. Kim J, Richter W, Aanstoot HJ, Shi Y, Fu Q, Rajotte R, Warnock G, and Baekkeskov S: Differential expression of GAD-65 and GAD-67 in human, rat and mouse pancreatic islets. Diabetes 42: 1799-1808, 1993.
47. Gianani R, Jackson R, and Eisenbarth GS: Evidence that the autoantigen of restricted ICA is GAD. Diabetes Res Clin Pract 14 (Suppl. 1): S13, 1991.
48. Buschard K, Molsted-Pedersen L, Kühl C, Damm P, Dyrberg T, and Petersen J. Glutamic acid decarboxylase (GAD65) autoantibodies predict clinical remission in type 1 diabetes diagnosed during pregnancy. (Abstract). Autoimmunity 21: 74.
49. Corcoy R, Morales J, Puig-Domingo M, Mauricio D, Adelantado JM, and de Leiva A: Increased frequency and lack of protection effect of restrictive islet cell autoantibodies in gestational diabetes (Abstract). Autoimmunity 21: 73, 1995.
50. Rubinstein P: Immunogenetics and the pathogenesis of insulin-dependent diabetes mellitus. In Autoimmunity and the Pathogenesis of Diabetes, Ginsberg-Fellner F, and McEvoy RC, Eds. Springer-Verlag, New York, 1990, pp. 29-55.
51. Füchtenbusch M, Hillebrand B, Hummel M, Keller E, Albert E, Durinovic-Bello I, Standl E, and Ziegler AG: Islet-cell associated autoimmunity and HLA-DR/DQ-haplotypes in gestational diabetes: a two year follow up (Abstract). Diabetologia 38 (Suppl. 1): A70, 1995.
52. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, and Eisenbarth GS: First degree relatives of patients with type I diabetes mellitus: islet cell antibodies and abnormal insulin secretion. N Engl J Med 313: 461-464, 1985.
53. Greenbaum CJ, Brooks-Worrell BM, Palmer JP, and Lernmark Å: Autoimmunity and prediction of insulin-dependent diabetes mellitus. In The Diabetes Annual/8, Marshall SM, and Home PD, Eds. Elsevier Science, Amsterdam, 1994, pp. 21-52.
54. Kühl C: Insulin secretion and insulin resistance in pregnancy and GDM: implications for diagnosis and management. Diabetes 40 (Suppl. 2): 18-24, 1991.
55. McCulloch DK, Klaff LJ, Kahn SE, Schoenfeld SL, Greenbaum CJ, Mauseth RS, Benson EA, Nepom GT, Shewey L, and Palmer JP: Nonprogression of subclinical β-cell dysfunction among first-degree relatives of IDDM patients. Diabetes 39: 549-556, 1990.
56. Genovese S, Bonifacio E, McNally JM, Dean BM, Wagner R, Bosi E, Gale EAM, and Bottazzo GF: Distinct cytoplasmic antibodies with different risks for type I (insulin-dependent) diabetes mellitus. Diabetologia 35: 385-388, 1992.
57. Bosi E, Becker F, Bonifacio E, Wagner R, Collins P, Gale EAM, and Bottazzo GF: Progression to type I diabetes in autoimmune endocrine patients with islet cell antibodies. Diabetes 40: 977-984, 1991.
58. Irvine WJ, McCallum CJ, Gray RS, and Duncan LJP: Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents. Lancet i: 1025-1027, 1977.
59. Groop LC, Bottazzo GF, Doniach D: Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes 35: 237-241, 1986.
60. Gottsäter A, Landin-Olson M, Fernlund P, Lernmark A, and Sundkvist G: Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 16: 902-910, 1993.
61. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, and Mackay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin dependent onset of the disease. Diabetes 42: 359-362, 1993.
62. Leslie RDG, and Elliott RB: Early environmental events as a cause of IDDM: evidence and implications. Diabetes 43: 843-850, 1994.
63. Leslie RDG, and Pozzilli P: Type I diabetes masquerading as type II diabetes. Diabetes. Care 10: 1214-1219, 1994.
64. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein J, Schatz DA, Schwartz S, Malone J, Shah S, Vadheim C, and Rotter JI: A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323: 1167-1172, 1990.
65. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, and Bottazzo GF: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147-149, 1990.
66. Zimmet PZ, Tuomi T, Mackay JR, Rowley MJ, Knowles W, and Cohen M: Latent autoimmune diabetes in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetic Med 11: 299-303, 1994.